Phenibut HCl Powder phenyl-GABA hydrochloride research material from Raw Lab Chems
Phenibut HCl Powder Price range: € 60,00 through € 100,00
Back to products
Noopept Powder omberacetam peptide-derived research material from Raw Lab Chems
Noopept Powder Price range: € 74,75 through € 645,00

Noopept Pellets – 10mg

Price range: € 17,50 through € 500,00

Noopept Pellets are described as compressed research units associated with N-phenylacetyl-L-prolylglycine ethyl ester, also known as omberacetam.

The named compound is a synthetic small molecule containing peptide-derived structural features and is discussed in experimental pharmacology and neuroscience literature.

The supplied source identifies a labeled ingredient quantity per pellet and presents the material for controlled analytical and non-clinical laboratory research.

Its stated scientific context includes chemical characterization, analytical method development, and investigation of neurotransmission-related molecular pathways in experimental systems.

The source reports CAS number 157115-85-0, molecular formula C₁₇H₂₂N₂O₄, and an approximate molecular weight of 318.4 g/mol. The formula and molecular weight are arithmetically consistent.

However, the actual batch identity, ingredient purity, excipient composition, finished-unit content, and content uniformity have not been independently verified.

The source refers to analytical verification and batch documentation where applicable, but no supporting reports were supplied.

The finished pellets are not established as certified reference materials or validated quantitative calibration standards.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12955 Category:
Description

Noopept Pellets 10mg – Omberacetam Research Material

Product Overview

Noopept Pellets are described as compressed research units associated with N-phenylacetyl-L-prolylglycine ethyl ester, commonly known as Noopept or omberacetam.

The named compound is a synthetic small molecule with peptide-derived structural features.

It is discussed in experimental pharmacological literature in connection with investigations of neurotransmission-related molecular pathways and neurotrophic-factor-associated signaling.

The supplied source identifies the product as a compressed pellet preparation intended for controlled analytical and neuroscience-oriented laboratory research.

The product description identifies a labeled ingredient quantity per pellet.

However, no actual finished-unit assay or content-uniformity report accompanied the information.

The labeled ingredient amount therefore remains a source-provided specification rather than an independently verified analytical result.

The source emphasizes documented handling, chemical characterization, purity assessment, and batch traceability.

These statements describe the intended research positioning but do not independently establish product quality or regulatory compliance.

The supplied information also identifies Noopept as a compound of interest in non-clinical investigations involving glutamatergic signaling and neurotrophic-factor-associated processes.

Such scientific contexts should be distinguished from product-specific experimental findings.

No receptor-binding dataset, biological activity report, or validated assay result for the actual finished pellets was supplied.

Noopept Pellets are not established here as certified reference materials, validated quantitative calibrators, or approved pharmaceutical preparations.

Chemical Identity & Classification

The supplied source identifies Noopept as N-phenylacetyl-L-prolylglycine ethyl ester, also known as omberacetam.

Its chemical structure contains peptide-related functional groups and an ethyl ester.

The supplied chemical information includes:

  • Common designation: Noopept
  • Alternative designation: Omberacetam
  • Chemical name: N-Phenylacetyl-L-prolylglycine ethyl ester
  • Reported CAS Registry Number: 157115-85-0
  • Reported molecular formula: C₁₇H₂₂N₂O₄
  • Approximate molecular weight: 318.4 g/mol
  • Chemical classification: Synthetic peptide-derived small molecule
  • Reported presentation: Compressed pellets
  • Labeled ingredient amount: Specified per finished pellet
  • Intended designation: Research Use Only

The reported molecular formula corresponds to an approximate molecular weight of 318.37 g/mol, consistent with the source’s rounded value.

This arithmetic consistency does not independently verify the identity of the actual product batch.

The chemical name identifies an L-prolyl structural component, but the supplied information does not include a batch-specific stereochemical verification report.

The source also does not establish whether the actual ingredient contains a particular salt, solvate, or other formulation component.

These details may be relevant when interpreting analytical measurements and quantitative material specifications.

Researchers may consult PubChem for public chemical-reference information, while ensuring that the selected database entry corresponds to the actual chemical form and stereochemical designation being examined.

Chemical & Physical Characteristics

The supplied source describes the product as compressed pellets.

No actual product-specific inspection report, pellet-dimension specification, total unit mass, or excipient list was provided.

The stated physical presentation therefore remains a source-provided description.

Noopept contains a phenylacetyl group, a proline-derived structural unit, and a glycine-derived ethyl ester segment.

These structural features distinguish the named compound from larger polypeptides and chemically unrelated small molecules.

However, structural classification alone does not establish the physicochemical characteristics of the finished formulation.    Noopept Pellets

The source does not provide experimentally verified melting-point data, solubility measurements, degradation profiles, or complete physical characterization.

The source also does not specify the additional ingredients that may be present in the compressed preparation.

Consequently, the chemical properties of the named ingredient should not be assumed to describe the entire finished pellet.

The source recommends cool, dry storage protected from light and moisture, with the original blister or container packaging kept intact.

No validated product-specific stability study or established shelf-life specification accompanied that recommendation.

Purity & Analytical Verification

The supplied source describes the ingredient as high purity and refers to analytical verification, often at or above 98% by HPLC or LC-MS where documented.

However, no actual batch-specific Certificate of Analysis or laboratory report accompanied the information.

The stated purity threshold therefore remains a supplier-provided claim rather than an independently verified result.

No chromatogram, mass spectrum, NMR spectrum, impurity profile, or independent laboratory certificate was supplied.  Noopept Pellets

Accordingly, no specific purity result can be confirmed for the actual product batch.

For a compressed preparation, the purity of the named ingredient and its actual quantity within a finished pellet are separate analytical characteristics.

An ingredient-purity result does not independently establish finished-unit content or content uniformity.

The source identifies analytical method development and reference-oriented research as intended laboratory contexts.

However, it does not establish that the finished pellets meet the requirements of a certified reference material.

No assigned measurement values, uncertainty statements, metrological traceability records, or independently verified finished-unit specifications were supplied.

Any product-specific analytical claims should be supported by actual batch documentation.

Quality Control & Batch Integrity

The supplied source refers to batch tracking, identity verification, purity data, and Certificate of Analysis-style documentation where applicable.  Noopept Pellets

These statements describe proposed or claimed quality-assurance practices.

No actual certificate, independent testing report, manufacturing audit, laboratory accreditation record, or batch-specific quality-control document accompanied the information.

They therefore remain unverified supplier statements.

For reproducible scientific documentation, relevant records may include verified chemical identifiers, confirmed chemical form, stereochemical information where available, batch number, analytical findings, receipt date, and available storage history.

For compressed preparations, the identity and purity of the named compound should be distinguished from the composition and consistency of the finished units.

The supplied information does not establish independently verified content uniformity, excipient composition, or quantitative accuracy of the labeled ingredient amount.

The existence of a Research Use Only designation does not itself demonstrate manufacturing quality or analytical traceability.  Noopept Pellets

Claims of consistent purity, identity, and formulation quality should be supported by actual records rather than inferred from general quality-assurance language.

Safety, Handling & Laboratory Precautions

Noopept is a synthetic small-molecule compound discussed in experimental pharmacological research.

The supplied source does not provide a complete product-specific toxicological assessment.

Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.

Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.

The compressed presentation does not establish safety for human or veterinary exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the actual finished-unit composition, purity, chemical form, and stereochemical characteristics have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.  Noopept Pellets

Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes blister packs or sealed pouches, protective packaging, controlled handling, and international shipping arrangements.

No actual packaging specification, container-validation report, or shipment-condition record was provided.

The source recommends storage in a cool, dry environment protected from light and moisture, with the original blister or container packaging kept intact.

No validated product-specific stability data was provided to establish a particular storage temperature or shelf life.

Laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.

The labeled ingredient quantity should be recorded as a source-provided specification unless independently verified.

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.

Intended Research Use & Market Positioning

The supplied scientific context places Noopept within analytical and non-clinical neuroscience research involving peptide-derived small molecules and neurotransmission-related pathways.

The source describes research interest in glutamatergic signaling, neurotrophic-factor-associated processes, and experimental molecular mechanisms.

These contexts identify areas of scientific investigation but do not establish product-specific pharmacological performance.

No independently verified biological activity dataset for the actual pellets was supplied.

The supplied Raw Lab Chems catalog includes Noopept Pellets, corresponding to the listing discussed here.

For comparative product-format context, Raw Lab Chems also lists Noopept Powder and Noopept Tablets.

These listings refer to the same named compound in different product presentations.

However, the supplied information does not establish equivalent chemical forms, ingredient purity, excipient composition, or analytical characteristics across the pellet, powder, and tablet preparations.

For compressed preparations, labeled ingredient quantity and finished-unit content uniformity are distinct from ingredient purity.

These catalog references should not be interpreted as evidence of analytical equivalence, certified reference-material status, or validated calibration performance.

Ordering, Availability & Fulfillment

The supplied source describes protective packaging and international shipping arrangements.

No current inventory record, shipment authorization, carrier documentation, or verified delivery information was supplied.

Consequently, no availability, delivery, customs-clearance, or transportation-compliance guarantee is asserted.

The regulatory treatment of Noopept may depend on the jurisdiction, chemical classification, import requirements, and intended laboratory activity.

Institutional acquisition, possession, transportation, importation, and exportation should be assessed under applicable laws.

Research-only labeling does not independently establish a regulatory exemption.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Noopept is a synthetic peptide-derived small molecule discussed in non-clinical pharmacological research.

Its acquisition, possession, transportation, importation, exportation, and laboratory investigation may be subject to applicable chemical, pharmaceutical, customs, and institutional requirements.

The supplied information does not establish universal legal status or regulatory authorization.

Institutions remain responsible for determining the applicable requirements and obtaining any necessary permissions.

No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.

Additional information
Quantity (pellets)

25

,

50

,

100

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Noopept Pellets – 10mg”
Shipping & Delivery